Skip to main content
OpenTrials
Completed

NCT Number: NCT00210678

A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation

The purpose of the study is to characterize intravaginal ejaculatory latency time (time between the start of vaginal intercourse and the start of intravaginal ejaculation) in men with and without premature ejaculation (PE) and to assess the validity of patient-reported outcomes.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This is a multinational, multicenter, observational study in men with and without PE. The study consists of three visits: one visit for screening and enrollment, and two visits for observation after 1 and 2 months (total duration of 8 weeks). No study treatment for PE is administered to patients during the course of the study. Patients and their partners are expected to attempt sexual intercourse at least 2 times a week during the 8-week study period and to use a stopwatch to record the intravaginal ejaculatory latency time (IELT) during intercourse. At visits during the observation period "patients" (and/or partners if partners are responsible for completing questionaires) also provide patient-reported outcomes (PROs) by answering several questionnaires that include the topics of control over ejaculation, satisfaction with sexual intercourse, personal distress, interpersonal difficulty, and self-esteem. The study will estimate the distribution of the average IELT values for men with PE and men without PE.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be in a stable, monogamous, sexual relationship with the same woman (18 years of age or older) for at least 6 months, who plan to maintain their relationship for the duration of the study
  • Must be in good general health
  • Patient and partner willing to avoid situations or activities that may have an effect on their sexual activity (eg, refrain from any preplanned surgery)

Exclusion criteria

  • Has history of drug abuse within the past 2 years
  • Has history of or current major psychiatric disorder such as mood disorders, anxiety disorders, schizophrenia, other psychotic disorders, or alcoholism
  • Must have erectile dysfunction
  • Patient who has decreased interest in sexual intercourse or has other forms of sexual dysfunction
  • Patient whose partner has decreased interest in sexual intercourse, painful intercourse, or other forms of female sexual dysfunction
  • Patient whose partner is more than 3 months pregnant

Treatment and study plan

No intervention

Behavioral

No treatment is given to the patients as this is an observational study.

Primary outcomes

  1. Change in Intravaginal Ejaculatory Latency Time (IELT)

    Time frame: Day 1 to Week 8

    Estimated distribution of the average IELT for both the premature ejaculation (PE) and non-PE populations will be calculated.

  2. Change in Patient-Reported Outcomes (PRO)

    Time frame: Week 4 and Week 8

    Additional evidence of reliability and validity of PROs for patients with and without PE and their partners will be expolred. The PROs will include different parameters related to (control over ejaculation, satisfaction with sexual intercourse, personal distress, and interpersonal difficulty).

Secondary outcomes

  1. Association between intravaginal ejaculatory latency time (IELT) and patient reportedout comes (PROs)

    Time frame: Up to Week 8

    Association between IELT and PROs used in this study will be explored.

  2. Utility of the Male Sexual Function Scale and Ejaculation Questionnaires

    Time frame: Day 1

    The study will explore utility of the Male Sexual Function Scale and Ejaculation Questionnaire as screening instruments.

  3. PROs and IELT as indicators to clasify PE status.

    Time frame: Up to Week 8

    The study will evaluate the ability of PROs and IELT to classify PE status

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Industry

Registry information

Official study title

An Observational Study to Evaluate Intravaginal Ejaculatory Latency Time and Patient-Reported Outcomes in Men With and Without Premature Ejaculation

Important dates

Study start
2005
Primary completion
2005
Study completion
2005
First posted
Sep 21, 2005
Registry last updated
Oct 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.